Ketogenic and Fasting Diets Show Promise Against Gastrointestinal Cancers

Gastrointestinal cancers represent a significant global health burden, driving researchers to explore innovative therapeutic approaches beyond conventional treatments. This review investigates two promising dietary interventions: ketogenic diet (KD) and fast-mimicking diet (FMD) as potential adjuvant therapies for GI cancers.

The ketogenic diet, characterized by high fat and extremely low carbohydrate intake, fundamentally alters cellular energy metabolism by inducing ketosis. This metabolic state deprives rapidly dividing cancer cells of their preferred glucose fuel source, potentially slowing tumor progression. Meanwhile, fast-mimicking diets simulate the beneficial effects of fasting while allowing limited food intake, triggering multiple anti-cancer mechanisms including enhanced immune surveillance, reduced systemic inflammation, and increased autophagy for cellular cleanup.

Preclinical and early clinical evidence suggests both dietary strategies may significantly enhance chemotherapy efficacy while reducing the debilitating side effects commonly associated with conventional cancer treatments. These findings are particularly relevant for gastrointestinal cancers, where treatment tolerance and quality of life considerations are paramount.

Despite these encouraging results, the authors emphasize that research specifically targeting gastrointestinal malignancies remains sparse. The biological mechanisms underlying these dietary interventions require deeper investigation to optimize protocols and ensure patient safety. Future studies must establish clear guidelines for implementation, identify suitable patient populations, and determine optimal timing relative to conventional treatments to maximize therapeutic benefit while minimizing potential risks.